| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009881697 |
| P356 | DOI | 10.1038/ONC.2011.54 |
| P932 | PMC publication ID | 4139014 |
| P698 | PubMed publication ID | 21460854 |
| P5875 | ResearchGate publication ID | 50989731 |
| P2093 | author name string | H Jiang | |
| S Zhang | |||
| L Zhang | |||
| D Miller | |||
| X Zhuang | |||
| H-G Zhang | |||
| J Mu | |||
| X Xiang | |||
| S Ju | |||
| W Grizzle | |||
| P2860 | cites work | Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. | Q24542505 |
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer | Q24603354 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
| Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma | Q24627680 | ||
| The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 | ||
| Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression | Q24647373 | ||
| MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA | Q24648090 | ||
| Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice | Q24657152 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| Metastasis: from dissemination to organ-specific colonization | Q29614295 | ||
| Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
| Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice | Q29619279 | ||
| E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. | Q34088774 | ||
| MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene | Q34107532 | ||
| Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. | Q34347783 | ||
| Epithelial-mesenchymal transition in gastric cancer (Review). | Q36307390 | ||
| Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. | Q36902961 | ||
| Comprehensive algorithm for quantitative real-time polymerase chain reaction | Q37276441 | ||
| Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. | Q37504561 | ||
| From mouse egg to mouse embryo: polarities, axes, and tissues. | Q37540152 | ||
| Epithelial-mesenchymal transition and cell cooperativity in metastasis | Q37593803 | ||
| The role of SATB1 in breast cancer pathogenesis. | Q38342821 | ||
| MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor | Q39840690 | ||
| The class I bHLH factors E2-2A and E2-2B regulate EMT. | Q39871514 | ||
| Mouse 4T1 breast tumor model | Q39989082 | ||
| SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis | Q40002893 | ||
| Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth | Q43225336 | ||
| miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. | Q53306726 | ||
| BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model | Q57982646 | ||
| EMT and MET in carcinoma—clinical observations, regulatory pathways and new models | Q60601176 | ||
| Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments] | Q73368658 | ||
| Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene | Q74141703 | ||
| Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth | Q80819610 | ||
| Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression | Q82372111 | ||
| Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer | Q82615791 | ||
| Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation | Q84374421 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3440-3453 | |
| P577 | publication date | 2011-04-04 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. | |
| P478 | volume | 30 |
| Q47246071 | A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells |
| Q36619011 | A functional variant in miR-155 regulation region contributes to lung cancer risk and survival |
| Q34952133 | Advances in the targeted therapy of liposarcoma |
| Q26851620 | Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity |
| Q36618503 | Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis. |
| Q47136104 | Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer. |
| Q37039800 | Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis |
| Q30934284 | Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data |
| Q34389624 | Dysfunctions associated with methylation, microRNA expression and gene expression in lung cancer |
| Q35539983 | Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis |
| Q35411076 | Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells |
| Q36844312 | Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer. |
| Q39509421 | FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. |
| Q55396969 | FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1. |
| Q42165154 | Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP. |
| Q34531593 | Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression |
| Q34999819 | Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression |
| Q92715390 | Intermedin promotes hepatic carcinoma cell proliferation through upregulation of miR-155 |
| Q36853829 | Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles |
| Q37600528 | Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs |
| Q46914425 | MIROR: a method for cell-type specific microRNA occupancy rate prediction |
| Q37660590 | MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression |
| Q39393414 | MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling |
| Q26771110 | MicroRNA Regulation of Epithelial to Mesenchymal Transition |
| Q39274635 | MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells |
| Q54328253 | MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. |
| Q41093491 | MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer |
| Q38840848 | MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis |
| Q90259781 | MicroRNA-155-5p suppresses the migration and invasion of lung adenocarcinoma A549 cells by targeting Smad2 |
| Q37706233 | MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer |
| Q34774540 | MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells |
| Q39433270 | MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact |
| Q64041638 | MicroRNAs and Long Non-coding RNAs in Genetic Diseases |
| Q55042978 | MicroRNAs as Biomarkers in Colorectal Cancer. |
| Q38043263 | MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. |
| Q34288205 | Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. |
| Q37059796 | OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer |
| Q47193672 | Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis |
| Q33881478 | Post-transcriptional processing of genetic information and its relation to cancer |
| Q36228603 | Prioritizing cancer-related key miRNA-target interactions by integrative genomics |
| Q37734886 | Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model |
| Q39458257 | Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition. |
| Q38191102 | Regulation of microRNAs in cancer metastasis. |
| Q58696594 | Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma |
| Q37424446 | Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors. |
| Q34648156 | Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer |
| Q42378295 | Suppression of tumor-derived Semaphorin 7A and genetic ablation of host-derived Semaphorin 7A impairs tumor progression in a murine model of advanced breast carcinoma |
| Q38584077 | The Role of MicroRNA in Hepatitis C Virus Replication |
| Q38170025 | The microRNA networks of TGFβ signaling in cancer |
| Q38177652 | Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. |
| Q34533633 | Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells |
| Q58080415 | miR-155 expression in anti-tumor immunity: the higher the better? |
| Q49544999 | miR-155 in cancer drug resistance and as target for miRNA-based therapeutics |
| Q36557263 | miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations. |
| Q38003705 | miRNAs in breast cancer: ready for real time? |
| Q92208779 | miRNA‑30a‑3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin‑like growth factor 1 receptor |
Search more.